ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Aging Is Critically Impacting the Efficacy of Immunosuppressants.

J. Schuitenmaker, K. Edtinger, M. Seyda, H. Uehara, M. Quante, A. ElKhal, S. Tullius.

Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Meeting: 2016 American Transplant Congress

Abstract number: B20

Keywords: Immunosuppression, Mice, Skin transplantation, T cells

Session Information

Date: Sunday, June 12, 2016

Session Name: Poster Session B: Allograft Rejection, Tolerance, and Xenotransplantation

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Aging Enhances Immunosuppressives Capacities of Tacrolimus By Functional Changes of CD4+ T-Cells
  • Dendritic Cells and Damage-Associated Molecular Patterns in Aging.

Immunosenescence is broadly affecting alloimmunity with major implications on immunosuppression. Older recipients have thus far been mostly excluded from clinical trials. Here, we dissected the effect of aging on the efficacy of Rapamycin and CTLA-4-Ig.

Skin grafts of young DBA/2 mice were transplanted onto young (2 months) and old (18 months) C57BL/6 mice. Mice received either Rapamycin (1 mg per kg per day, i.p.), CTLA-4-Ig (0,2 mg per day i.p.) or PBS. Grafts in older, untreated recipients survived significantly longer (7 vs. 9 days; p=0,01), indicating that immunosenescence promotes allograft survival. Treatment with the costimulatory blocker CTLA-4-Ig prolonged graft survival modestly in an age-independent fashion (10 vs. 11 days in young and old animals, resp.). In contrast, Rapamycin prolonged graft survival in an age-specific fashion: while the median graft survival was modestly extended in young recipients (12 days), graft survival was significantly prolonged in old recipients (19 days; p=0,008). Next, we dissected age-specific effects of CTLA-4-Ig and Rapamycin on alloimmunity. Subsequent to costimulatory blockade, both CD4+ and CD8+ T cells significantly declined in young recipients only (p=0,003 and P=0.02, respectively). However, Rapamycin treatment had been linked to a significantly more pronounced decrease of CD4+ T cells in old recipients (p=0.0005). Moreover, we observed a significant decline of CD11c+MHC class II+ cells in old Rapamycin treated recipients (p=0.01).

Our data demonstrate that aging is critically impacting the efficacy of Rapamycin and CTLA-4-Ig emphasizing on the necessity of age-adapted immunosuppression.

CITATION INFORMATION: Schuitenmaker J, Edtinger K, Seyda M, Uehara H, Quante M, ElKhal A, Tullius S. Aging Is Critically Impacting the Efficacy of Immunosuppressants. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Schuitenmaker J, Edtinger K, Seyda M, Uehara H, Quante M, ElKhal A, Tullius S. Aging Is Critically Impacting the Efficacy of Immunosuppressants. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/aging-is-critically-impacting-the-efficacy-of-immunosuppressants/. Accessed January 27, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.